Corporate Office: Plot No. 412-415, Nimai T ower, 3rd Floor, Phase-IV , Udyog Vihar,  
Sector-18, Gurugram -122015, Haryana (India) 
 +91 124 4406710;  info@jagsonpal.com;  www.jagsonpal.com                    Ph.: E-mail: Website:
 L74899DL1978PLC009181CIN :.  
Regd. Office: Innov8  3  Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India), rd
13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070Mumbai Office:  
November 18, 2025 
 
The Department of Corporate Services- Listing 
BSE Ltd, 
Phiroze Jeejeebhoy Towers, 
Dalal Street, Mumbai-400 001 
Scrip Code: 507789 
The Department of Corporate Services- Listing 
National Stock Exchange of India Ltd  
Exchange Plaza, C-1, Block G, 
Bandra Kurla Complex, Bandra (E) Mumbai – 400 051 
Symbol: JAGSNPHARM 
 
 
Subject: Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 
2022 (“JPL ESOP 2022”) 
Dear Sir/ Madam, 
 
Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are 
pleased to inform you that the Nomination and Remuneration Committee has issued and allotted 56,571 Equity 
Shares of Rs. 2/- each under JPL ESOP 2022, to the eligible employees of the Company, upon exercise of vested 
options. These shares shall rank Pari-passu with the existing equity shares of the Company, in all respects. 
 
Consequent to the above allotment, the paid-up share capital of the Company has increased from Rs. 
13,34,49,398 (constituting of 6,67,24,699 equity shares of Rs. 2/- each) to Rs. 13,35,62,540 (constituting of 
6,67,81,270 equity shares of Rs. 2/- each). 
 
Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, is 
attached herewith. 
 
We request you to take the above on record.  
Thanking you, 
For Jagsonpal Pharmaceuticals Limited 
 
 
 
Pratham Rawal 
Company Secretary & Compliance officer 
 
  
JAGSONPAL PHARMACEUTICALS LIMITED U • -... akht 
UAGSONPAU A CSR Initiative 
Corporate Office: Plot No. 412-415, Nimai T ower, 3rd Floor, Phase-IV , Udyog Vihar,  
Sector-18, Gurugram -122015, Haryana (India) 
 +91 124 4406710;  info@jagsonpal.com;  www.jagsonpal.com                    Ph.: E-mail: Website:
 L74899DL1978PLC009181CIN :.  
Regd. Office: Innov8  3  Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India), rd
13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070Mumbai Office:  
 
Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 
 
For Jagsonpal Pharmaceuticals Limited 
 
 
 
Pratham Rawal 
Company Secretary & compliance officer 
Sr. 
No. 
Particulars 
1. Company name and address of Registered Office: Jagsonpal Pharmaceuticals Limited and 
Registered   Office- Innov8, 3 rd Floor, Plot 
No. 211, Okhla Phase-3, New Delhi- 110020  
2.  Name of the recognized Stock Exchanges on which the 
company's shares are listed: 
BSE Limited and National Stock Exchange of 
India Limited 
3. Filing date of the statement referred  in Regulation 
10(b) of the SEBI (Share Based Employee Benefits) 
Regulations, 2021 with Stock Exchange: 
July 26, 2022 - BSE   
July 27, 2022 - NSE 
4. Filing Number, if any: NA 
5. Title of the Scheme pursuant to which shares are 
issued, if any: 
Jagsonpal Pharmaceuticals Limited 
Employee Stock Option Plan, 2022 
6. Kind of security to be listed:  Equity Shares 
7. Par value of the shares Rs. 2/- 
8. Date of issue of shares November 18, 2025 
9. Number of shares issued: 56,571 
10. Share Certificate No., if applicable: NA 
11. Distinctive number of the share, if applicable: 6,67,24,700 to 6,67,81,270 
12. ISIN Number of the shares if issued in Demat: INE048B01035 
13. Exercise price per share: Rs. 94.00/- for 46,246 Equity shares, 
Rs. 113.60/- for 9,125 Equity shares and,  
Rs. 115.60/- for 1,200 Equity shares  
14. Premium per share: Rs. 92.00/- for 46,246 Equity shares,  
Rs. 111.60/- for 9,125 Equity shares and  
Rs. 113.60/- for 1,200 Equity shares 
15. Total Issued shares after this issue: 6,67,81,270 
16. Total Issued share capital after this issue: Rs. 13,35,62,540 
17. Details of any lock-in on the shares: NA 
18. Date of expiry of lock-in: NA 
19. Whether shares identical  in all respects to existing 
shares if not, when will they become identical? 
Yes, the shares rank pari passu with the 
existing shares 
20. Details of listing fees, if payable: NA 
JAGSONPAL PHARMACEUTICALS LIMITED U • -... akht 
UAGSONPAU A CSR Initiative 
